Tag: NYSEMKT:HEB

Finance

Trader’s Recap : Twitter Inc. (NYSE:TWTR), Hemispherx (NYSEMKT:HEB), SBCF, Jewett-Cameron Trading (NASDAQ:JCTCF), Sprague Resources LP (NYSE:SRLP)

Twitter Inc. (NYSE:TWTR) said it paid $134.1 million for social data provider Gnip Inc. in May. The price included $107.3 million in cash, with the rest in stock, the San Francisco-based company said in a regulatory filing on Tuesday. Twitter, Inc. (NYSE:TWTR) belongs to Technology sector. Its net profit margin is -87.60% and weekly performance is -0.46%. On last trading day company shares ended up … Continue reading Trader’s Recap : Twitter Inc. (NYSE:TWTR), Hemispherx (NYSEMKT:HEB), SBCF, Jewett-Cameron Trading (NASDAQ:JCTCF), Sprague Resources LP (NYSE:SRLP)

Jason Knox
Finance

Top News – GoPro Inc (NASDAQ:GPRO) , Facebook (NASDAQ:FB) , Duke Realty (NYSE:DRE) , Hemispherx BioPharma (NYSEMKT:HEB) , Cobra Electronics (NASDAQ:COBR)

GoPro, Inc. (NASDAQ:GPRO) today released four exclusive videos to the Xbox community to mark the launch of its GoPro Channel for the Xbox One® video game and entertainment system from Microsoft – an entertainment and e-commerce app that allows Xbox Live members worldwide* to stream GoPro content on-demand, share favorite videos, and purchase GoPro cameras and accessories.   GoPro Inc (NASDAQ:GPRO) stock performance was 3.66% in … Continue reading Top News – GoPro Inc (NASDAQ:GPRO) , Facebook (NASDAQ:FB) , Duke Realty (NYSE:DRE) , Hemispherx BioPharma (NYSEMKT:HEB) , Cobra Electronics (NASDAQ:COBR)

Jayne Crisman
Finance

Biotech Active Runners: Hemispherx BioPharma (NYSEMKT:HEB), Rexahn Pharmaceuticals (NYSEMKT:RNN), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)

Hemispherx Biopharma, Inc. (NYSE MKT:HEB) participated in the 11th Biennial International Research and Clinical Conference  held in San Francisco, California, USA, March 20-23, 2014. The title of the presentation is “Differential Exercise Responses to Rintatolimod [Ampligen(R)] Exhibited by Patients with Severe Chronic Fatigue Syndrome (CFS)”. This Phase III prospective, double-blind, randomized, placebo-controlled trial was conducted at twelve centers by leading researchers in fatigue and post-exertional … Continue reading Biotech Active Runners: Hemispherx BioPharma (NYSEMKT:HEB), Rexahn Pharmaceuticals (NYSEMKT:RNN), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)

Jason Knox